About john.davis

This author has not yet filled in any details.
So far john.davis has created 23 blog entries.

Applied DNA Announces Availability and First Customer Shipment of New Linea™ IVT Evaluation Kit

STONY BROOK, N.Y. – August 29, 2023 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”), a leader in PCR-based DNA technologies, today announced the general availability of Linea™ IVT platform evaluation kits (the "Kit") and the first shipment of a Kit to an existing Linea™ IVT Template customer. The newly launched Kit, comprised of [...]

Applied DNA Significantly Expands Addressable Market for Linea™ COVID-19 Assay Kit via Successful Amendment to FDA EUA

STONY BROOK, N.Y. – November 25, 2020 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that the U.S. Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) amendment that expands the installed base of [...]

Applied DNA Announces Linear DNA Orders from New Contract Research Customers for Use in RNA Vaccine and Adeno-Associated Virus Applications

STONY BROOK, N.Y. – November 2, 2020 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that it received orders for its linear DNA to be evaluated in an RNA vaccine and Adeno-Associated Virus (AAV) production from two [...]

Applied DNA to Increase COVID-19 Surveillance Testing Utility for its Linea™ COVID-19 Assay Kits Through Expanded Use of Robotic Automation

STONY BROOK, N.Y. – October 30, 2020 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables diagnostics in vitro, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting, and anti-theft technology, today announced that it plans [...]

Applied DNA to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 15

STONY BROOK, N.Y.  September 2, 2020 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft technology, today announced that Dr. James A. Hayward, [...]

2022-10-31T10:10:21-04:00Categories: Press Release|Tags: , |

Colorcon, Inc. Launches On-Dose Authentication Platform From Applied DNA Sciences

STONY BROOK, N.Y., December 23, 2019 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions and nucleic acid-based biotherapeutic development, announced today that its partner, Colorcon, a world leader in the development and supply of film coating systems and excipients, formally launched the On-Dose [...]

Applied DNA Sciences Regains Compliance with Nasdaq Listing Standards

STONY BROOK, N.Y., November 25, 2019 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”) or (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions and nucleic acid-based biotherapeutic research, today announced that it has received notification from Nasdaq that the Company has regained compliance with Nasdaq’s minimum [...]

2022-10-31T14:33:42-04:00Categories: Press Release|Tags: , |

Successful DNA Tagging of Leather at one of the World’s Largest Tanneries

STONY BROOK, N.Y., November 12, 2019 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA,” “we,” “our” or the “Company””), a leader in large-scale Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today the successful DNA tagging of leather at one of the world’s largest tanneries based in Asia. The work follows a successful research project [...]

Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors

STONY BROOK, N.Y., November 8, 2019 –  Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions and nucleic acid-based biotherapeutic research, today announced the appointment of Scott L. Anchin to its Board of Directors following the resignation of [...]

Go to Top